KNOXVILLE, Tenn. (Ivanhoe Newswire) -- It’s the leading cause of cancer deaths in both men and women, higher than colon, breast, and prostate cancer. Each year, lung cancer strikes more than 220 thousand people. It will kill 160 thousand, but adding something to chemotherapy could help beat the disease.
“It keeps my mind at peace because I know that I’m not alone,” Kimberly Thomas, who has small cell carcinoma, told Ivanhoe.
Kimberly has small cell carcinoma, a very aggressive form of lung cancer, but something new could help her overcome it.
University of Tennessee Medical Center’s Dr. Wahid Hanna is helping investigate how adding immune-boosting antibodies to chemotherapy drugs could help patients like Kim.
“If you have a cell that is requiring oxygen and you interfere with the nutrition, you interfere with the way it gets the cells to grow, that’s it it’ll die,” Wahid T. Hanna, MD, Professor of Medicine at The University of Tennessee Medical Center, told Ivanhoe.
The antibody attaches itself to cancer cells, making the cancer vulnerable to being destroyed by a patient’s own immune system.
After six rounds of the chemotherapy, combined with the antibody, the tumor in Kimberly’s lung has shrunk by more than half.
“It makes me feel ecstatic that there’s hope,” Kimberly said.
Kimberly and her daughter Victoria hope the tumor will eventually disappear so they can enjoy more quality time together.
“We have definitely gotten closer and it’s kind of a blessing,” Victoria Marlow, Kimberly’s daughter, told Ivanhoe.
After patients complete the combination treatment, they can choose to continue taking the antibody without the chemotherapy. Patients from around the US and around the world are being recruited to take part in the phase two study. MORE.
If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Andrew Mcintosh at firstname.lastname@example.org